Simple Summary US-MRI fusion biopsy is established as a technique of reference for the
detection of clinically significative prostate cancer compared to the ultrasound “template” …

Prostate MRI is now established as a first-line investigation for individuals presenting with
suspected localized or locally advanced prostate cancer. Successful delivery of the MRI …

Background Prostate magnetic resonance imaging (MRI) is now standard for assessment of
suspected prostate cancer (PCa). A variety of approaches to MRI-based targeting has …

Multiparametric MRI of the prostate is now recommended as the initial diagnostic test for
men presenting with suspected prostate cancer, with a negative MRI enabling safe …

Introduction Prostate mpMRI was introduced in 2011 as a secondary test and subsequently
integrated into a prostate cancer (PCa) diagnostics unit representing a population of …

Simple Summary With the consolidation of multiparametric resonance of the prostate as an
effective method in the diagnosis of clinically significant prostate cancer (csPCa), robot …

Purpose of review: In recent decades, there has been an increasing role for magnetic
resonance imaging (MRI) in the detection of clinically significant prostate cancer (csPC). The …

Background The optimal diagnostic pathway for prostate cancer (PCa) is evolving, requiring
further evaluation in a randomized controlled trial. Purpose To assess the diagnostic …

Prostate cancer (PCa) has become a common disease among middle-aged and elderly
men. The lipoxygenase (LOX) pathway plays a crucial role in the occurrence, development …

MRI-guided targeted biopsy (MRGB) was recommended as part of biopsy paradigm of
prostate cancers by current guidelines. This study aimed to analyze the diagnostic efficacy of …